Home
|
About us
|
Editorial board
|
Ahead of print
|
Current issue
|
Archives
|
Submit article
|
Instructions
|
Search
|
Subscribe
|
Advertise
|
Contacts
|
Login
Users Online: 658
Article Access Statistics
Year : 2018 | Volume: 9 | Issue Number: 4 | Page: 187-188
LETTER TO EDITOR
From “Glivec
®
” to “Prevnar 13
®
”: How strong is the Indian drug patenting system?
Raj Gerard Marshall
Number of times this article was viewed
1901
Number of times this article has been printed from the site
107
Number of times this article was emailed to others
0
Remarks given by readers [
Read
]
0
Feedback
Subscribe
Back To Article
Sitemap
|
What's New
Feedback
|
Copyright and Disclaimer
|
Privacy Notice
© Perspectives in Clinical Research | Published by Wolters Kluwer -
Medknow
Online since 20
th
October, 2010